If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
68.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 6.00 (9.231%)
Market Cap: £175.12m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Portfolio Update

28 Nov 2025 13:34

RNS Number : 4934J
Unicorn AIM VCT PLC
28 November 2025
 

Unicorn AIM VCT PLC

LEI: 21380057QDV7D34E9870

Portfolio Update

 

The Directors of Unicorn AIM VCT plc (the "Company") are pleased to announce that the Company, together with other shareholders of Hasgrove Limited ("Hasgrove"), has entered into an agreement with Castik Capital S.à r.l. ("Castik") in connection with Castik's proposed acquisition of a majority stake in Hasgrove.

 

As part of the transaction, Unicorn AIM VCT plc, together with the former Chairman and members of the executive management team, will realise a portion of their investment for cash and, alongside Castik, will become shareholders in a new holding company established to acquire Hasgrove (the "Newco").

 

Hasgrove is currently the largest holding in the Company's portfolio and was most recently valued at £46.7 million in the Company's Net Asset Value ("NAV") update released as at 31 October 2025. Subject to completion of the transaction, receipt of the cash consideration and the finalisation of valuations, the Board expects the NAV to be materially higher than that reported as at 31 October 2025. In connection with the Transaction, the Company will conduct a fair value review of its interest in Newco and publish an updated NAV as soon as practicable.

 

The Company expects to receive total net proceeds of approximately £87 million from the transaction. Of this amount, approximately £22 million is expected to be settled through the issuance of shares in Newco, with the remaining £65m expected to be received in cash (in each case subject to completion adjustments). The Board will consider whether to declare a special dividend following completion and once final proceeds have been received, with further details (including quantum and timing) to be announced in due course.

 

Unicorn Asset Management Limited ("Unicorn"), the Company's Investment Manager, commented:

 

"Unicorn has been proud to partner with Hasgrove since backing the business at IPO in 2006, providing strategic input and working closely with the leadership team throughout its journey. This transaction delivers another significant realisation for Unicorn AIM VCT plc shareholders, crystallising significant value whilst crucially maintaining exposure to what we believe is a high-quality, cash-generative business with strong growth potential. Having engaged closely with both management and Castik, we are confident this partnership represents the right next step and look forward to working together as Hasgrove enters this exciting new chapter."

 

Tim Woodcock, Chair, Unicorn AIM VCT plc. commented:

 

"The Unicorn team have delivered an excellent result in both realising considerable cash proceeds from the investment for the Company's shareholders, and negotiating a deal which enables the VCT to participate in the future growth of Hasgrove"

 

For further information please contact:

 

Investment Manager:

Unicorn Asset Management Limited

Telephone: 020 7253 0889

Email:info@unicornam.com

 

Company Secretary:

ISCA Administration Services Limited

Telephone: 01392 487056

Email:unicornaimvct@iscaadmin.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUXVLFLEFLXFBL
Date   Source Headline
3rd Aug 202011:02 amRNSTotal Voting Rights
23rd Jul 202012:51 pmRNSInterim Management Statement
17th Jul 20207:36 amRNSTransaction in Own Shares
7th Jul 20203:54 pmRNSNet Asset Value(s)
1st Jul 202010:20 amRNSTotal Voting Rights
22nd Jun 20202:46 pmRNSTotal Voting Rights
22nd Jun 20202:45 pmRNSDirector/PDMR Shareholding
22nd Jun 20208:00 amRNSIssue of Equity
18th Jun 20203:39 pmRNSNet Asset Value(s)
12th Jun 20209:39 amRNSOffer Update – Close of Applications for Offer
4th Jun 20209:59 amRNSNet Asset Value(s)
18th May 20205:08 pmRNSDirectorate Change
18th May 20203:52 pmRNSHalf-year Report
6th May 20205:33 pmRNSNet Asset Value(s)
1st May 202011:03 amRNSTotal Voting Rights
9th Apr 20205:32 pmRNSTransaction in Own Shares
6th Apr 20204:36 pmRNSDirector/PDMR Shareholding
6th Apr 20209:43 amRNSTotal Voting Rights
6th Apr 20207:00 amRNSIssue of Equity
1st Apr 20205:06 pmRNSNet Asset Value(s)
26th Mar 202010:43 amRNSPublication of Suppl.Prospcts
25th Mar 20202:33 pmRNSNet Asset Value and Offer Update
24th Mar 20206:28 pmRNSNet Asset Value(s)
17th Mar 20207:00 amRNSStatement re Offer for Subcription
11th Mar 202010:04 amRNSNet Asset Value(s)
2nd Mar 202011:05 amRNSTotal Voting Rights
11th Feb 202012:35 pmRNSOffer for Subscription and Issue of Prospectus
6th Feb 202011:51 amRNSIssue of Equity
4th Feb 20205:39 pmRNSNet Asset Value(s)
3rd Feb 202010:47 amRNSTotal Voting Rights
30th Jan 20205:34 pmRNSResult of AGM
28th Jan 20209:25 amRNSInterim Management Statement
20th Jan 20209:50 amRNSTransaction in Own Shares
14th Jan 202010:03 amRNSNet Asset Value(s)
6th Jan 20203:48 pmRNSIntention to launch an Offer
2nd Jan 20209:47 amRNSTotal Voting Rights
16th Dec 201911:15 amRNSTransaction in Own Shares
11th Dec 201911:02 amRNSNet Asset Value(s)
4th Dec 20197:54 amRNSFinal Results
15th Nov 201912:21 pmRNSDirector Declaration
12th Nov 201910:31 amRNSNet Asset Value(s)
1st Nov 20199:48 amRNSTotal Voting Rights
16th Oct 201912:08 pmRNSTransaction in Own Shares
11th Oct 20199:54 amRNSNet Asset Value(s)
1st Oct 20199:26 amRNSTotal Voting Rights
11th Sep 20195:02 pmRNSTransaction in Own Shares
6th Sep 201910:07 amRNSNet Asset Value(s)
2nd Sep 20191:13 pmRNSTotal Voting Rights
14th Aug 201911:53 amRNSDirector/PDMR Shareholding
9th Aug 20195:59 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.